What to expect from Medicare in 2017? As indicated through Medicare's Open Enrollment period in 2016 – Higher prescription drug prices and out-of-pocket costs.
It’s all well and good to secure your Medicare plan, but one of the many, many things you and your financial planner need to be aware of is the growing list of Medicare plan providers who are under sanctions from the Centers for Medicare and Medicaid Services.
Several high profile cases in the last year have demonstrated how the cost for life-saving drugs or treatment can increase dramatically without warning. The narratives of Epipen and the anti-parasitic drug Daraprim tell the heart-rending tale of patients abruptly unable to afford a drug that they desperately needed.